J. Goldman & Co’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-19,705
| Closed | -$129K | – | 411 |
|
|
2024
Q3 | $129K | Hold |
19,705
| – | – | ﹤0.01% | 306 |
|
|
2024
Q2 | $143K | Sell |
19,705
-8,295
| -30% | -$60.1K | ﹤0.01% | 286 |
|
|
2024
Q1 | $213K | Sell |
28,000
-28,042
| -50% | -$213K | 0.01% | 251 |
|
|
2023
Q4 | $255K | Buy |
56,042
+2,042
| +4% | +$9.29K | 0.01% | 187 |
|
|
2023
Q3 | $213K | Hold |
54,000
| – | – | 0.01% | 200 |
|
|
2023
Q2 | $169K | Sell |
54,000
-67,500
| -56% | -$211K | 0.01% | 217 |
|
|
2023
Q1 | $550K | Buy |
+121,500
| New | +$550K | 0.02% | 181 |
|
|
2021
Q2 | – | Sell |
-11,441
| Closed | -$167K | – | 357 |
|
|
2021
Q1 | $167K | Sell |
11,441
-60,903
| -84% | -$889K | 0.01% | 311 |
|
|
2020
Q4 | $1.55M | Buy |
+72,344
| New | +$1.55M | 0.08% | 170 |
|